Lannett Company Inc


Lannett Company, Inc.

Lannett Company, Inc. founded in 1942, develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms to customers throughout the United States. Lannett markets its products primarily to drug wholesalers, retail drug chains, distributors, and government agencies.

We employ a staff of dedicated people who work together to produce drug products that sick people can afford to buy that will treat their illness, make them well, reduce suffering and improve the quality of their lives.

News & Events

10/29/14 LANNETT RECEIVES FDA APPROVAL FOR LETROZOLE TABLETS USP 2.5 MG

Lannett Company, Inc. (NYSE: LCI) today today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Letrozole Tablets USP, 2.5 mg, the therapeutic equivalent to the reference listed drug, FemaraŽ Tablets, 2.5 mg, of Novartis Pharmaceuticals Corporation. Read More

10/29/14 LANNETT TO PRESENT AT THE 2014 CREDIT-SUISSE HEALTHCARE CONFERENCE ON NOV 11

Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the Credit-Suisse 2014 Healthcare Conference on Tuesday, November 11, 2014, at 4:30 p.m. Mountain Standard Time (6:30 p.m. Eastern Standard Time) at The Biltmore Hotel in Phoenix, AZ. Read More
Listen To Audio Webcast

10/23/14 Lannett Announces Preliminary Fiscal 2015 First Quarter Net Sales Of Approximately $93 Million, EPS Between $0.91 And $0.94 -Company to Report Full Financial Results, Host Conference Call on November 3-

Lannett Company, Inc. (NYSE: LCI) today announced that it expects to report fiscal 2015 first quarter net sales of approximately $93 million and diluted earnings per share between $0.91 and $0.94. Read More
Listen To Audio Webcast

09/30/14 CLASS ACTION LAWSUIT AGAINST LANNETT VOLUNTARILY DISMISSED WITHOUT PREJUDICE

Lannett Company, Inc. (NYSE: LCI) today announced that the class action lawsuit filed against the company and certain officers in the United States District Court for the Eastern District of Pennsylvania, entitled Schaefer v. Lannett Company, Inc., et al., has been voluntarily dismissed without prejudice by the plaintiff. Read More

09/22/14 Lannett Launches Oxycodone Hydrochloride Oral Solution

Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced shipping its recently approved Oxycodone Hydrochloride Oral Solution USP, 100 mg per 5 mL. According to IMS, annualized sales of Oxycodone Hydrochloride Oral Solution USP, 100 mg per 5 mL, at Average Wholesale Price (AWP) were approximately $43 million. Read More

Authorized Distributors of Record

Lannett Company Inc is the Authorized Distributors of Record for many products.
Download the full list.

Community Relations

Our dedicated employees strive to position Lannett as an industry leader that is focused on quality and integrity, as well as giving back to the community we serve. Lannett has a history of supporting schools, hospitals, veterans and their families, institutions, rehabilitation centers, cancer research, as well as the local fire and police departments. Read More.

Wholesale distributors that display the VAWD Seal as part of their accreditation have undergone a criteria compliance review, including a rigorous review of their operating policies and procedures, licensure verification, survey of facility and operations, background checks, and screening through the NABP Clearinghouse. Accredited facilities are reviewed annually and undergo a site survey every three years.


Made in USA

Made in America